Canada’s vaccine deliveries further threatened as Europe mulls export controls
OTTAWA -- Canada's anxiety-laden COVID-19 vaccine programs are facing further threats as Europe warns drug makers it might impose export controls on European-made vaccine doses.
All of Canada's current vaccine doses from Pfizer-BioNTech and Moderna are made in Europe, potentially putting at risk the entirety of Canada's vaccine deliveries.
Europe -- like Canada -- is being shorted on deliveries from Pfizer as the company slows production to expand its plant in Belgium.
But AstraZeneca has also now informed Europe productions issues will reduce initial deliveries of its vaccine, which Europe is expected to approve for use later this week.
European Commission president Ursula von der Leyen says in a tweet today that the world's largest trading bloc will establish "a vaccine export transparency mechanism."
Canada has no ability currently to produce COVID-19 vaccines but Prime Minister Justin Trudeau has insisted repeatedly that Canada will get enough vaccine doses for all Canadians who want it by the end of September.
Mia Rabson, The Canadian Press
- Canada to receive record 640K vaccine doses this week with Pfizer, Moderna deliveries
- Deliveries of COVID-19 vaccine doses to Canada set to more than quadruple next week
- Vaccine deliveries slow this week as Canada expecting 600K Pfizer doses
- Canada to receive 2M vaccine doses this week as Pfizer-BioNTech ramp up deliveries
- Pfizer-BioNTech delays vaccine deliveries to Canada due to production issues
- Thirteen tickets won a massive lottery prize in Ontario but no jackpot
- UPDATE: Brampton teen drowns in Halton Hills area
- Mississauga enters first stage of reopening as COVID-19 restrictions loosen across Ontario
- Mississauga, Brampton vaccine clinics taking place this weekend
- Here's what's open in Mississauga under first phase of reopening